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Abstract 
 
Examining experiential avoidance as a mediator of the relation between 
anxiety sensitivity and depressive symptoms 
 
Aliza Tova Stein, MA 
The University of Texas at Austin, 2019 
 
Supervisor: Jasper Smits 
 
Initial evidence suggests that experiential avoidance (EA) mediates the relation 
between anxiety sensitivity (AS) and depression. We examined the AS-EA-depression 
pathway, examining both concurrent, and prospective (cross-lag), mediation models. 
Utilizing data from a study that examined the effects of exercise on AS (N = 60), we 
modeled depressive symptoms, EA, and AS over four time points. Time-varying predictors 
were disaggregated into between- subjects (each person’s mean level of the predictor) and 
within- subjects change (each person’s deviations, at each time point, from their mean level 
on the predictor) components. Tests of the concurrent relations were partially consistent 
with predictions, with mean EA levels, but not within-subjects changes in EA, partially 
mediating the relation between AS and depression symptom severity. However, the 
prospective, cross-lag mediation model, in which AS predicted future EA controlling for 
previous EA, and EA predicted future depression, controlling for previous depression, 
yielded no significant effects. These results suggest that observed between-subjects 
mediation findings, found here and in previous studies, may not replicate using more 
 v 
stringent, quasi-causal, cross-lag mediation analyses. These results highlight the 
importance of estimating causal pathways in mediation analyses. Clinical implications and 
directions for future research are discussed. 
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Chapter 1: Introduction1 
Anxiety sensitivity (AS) is a tendency to fear bodily sensations associated with 
anxious arousal due to the belief that these will cause physical, social, or cognitive harm 
(Reiss, 1991). Although initially conceptualized as relating specifically to panic disorder 
(Cox, Borger, & Enns, 1999), AS has emerged as a transdiagnostic risk factor for a range 
of psychopathology (Otto et al., 2016; Schmidt, Zvolensky, & Maner, 2006). In addition 
to panic disorder, elevated AS confers vulnerability to the development of other anxiety 
disorders (Cox et al., 1999; Maller & Reiss, 1992), substance use disorders (Lejuez, 
Paulson, Daughters, Bornovalova, & Zvolensky, 2006; Leventhal & Zvolensky, 2015) 
and borderline personality disorder (Gratz, Tull, & Gunderson, 2008; Lilienfeld & Penna, 
2001). There has also been growing evidence suggesting that AS, particularly the 
cognitive concerns dimension, is related to depression (Allan, Capron, Raines, & 
Schmidt, 2014; Naragon-Gainey, 2010). Furthermore, reductions in AS have been 
associated with reduced symptoms of panic (Hazen, Walker, & Eldridge, 1996; Schmidt, 
Raines, Allan, & Zvolensky, 2016) as well as symptoms of depression, anxiety, and 
suicidal ideation (Otto, Pollack, Fava, Uccello, & Rosenbaum, 1995; Schmidt, Capron, 
Raines, & Allan, 2014; Schmidt, Norr, Allan, Raines, & Capron, 2017). Reductions in 
anxiety sensitivity have also been associated with positive treatment outcomes for health 
behaviors, such as smoking, problematic alcohol use, and insomnia (for review, see Otto 
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Therapy (2018) http://www.tandfonline.com/10.1080/16506073.2018.1546768. All authors contributed 
equally to the publication of this manuscript. 
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et al., 2016). These findings suggest that, although AS has been conceptualized as a 
dispositional variable (Reiss & Havercamp, 1996), it is malleable with treatments such as 
interoceptive exposure, cognitive restructuring, and aerobic exercise (for review, see 
Smits, Berry, Tart, & Powers, 2008). Hence, AS is an important target for interventions 
that aim to prevent or ameliorate psychological disorders (Smits, Otto, Powers, & Baird, 
2018). 
Otto and colleagues (Otto et al., 2016; Otto, Smits, Fitzgerald, Powers, & Baird, 
2018; Otto & Smits, 2018) have discussed the mechanism by which AS confers risk for 
psychological and related disorders. Specifically, they describe AS an “amplification” 
factor, such that elevated levels of AS potentiate the aversiveness of negative affective or 
somatic states, which promotes the use of maladaptive emotional regulation strategies in 
an effort to prevent, avoid, or escape from such experiences. In the context of panic 
disorder, for example, anxiety sensitivity signals threat following changes in somatic 
arousal that occur because of stress or physical activity, which results in fear and 
promotes actions that help the person manage these false alarms (e.g., rescue 
medications, escape). In the context of depression, AS may also amplify emotions (e.g., 
sadness, guilt, worthlessness, or hopelessness). The motivation to escape from these 
intense internal experiences (i.e., experiential avoidance), is thus likely to increase in 
persons with elevated AS, which in turn can reinforce the cycle (i.e., depressed state – 
withdrawal/avoidance – loss of reward – depressed state) that is characteristic of 
depression (Zvolensky & Forsyth, 2002).  
 3 
There is some evidence supporting the hypothesis that experiential avoidance 
(EA) mediates the AS-depression relation. First, reflecting evidence for the effect of the 
independent variable (AS) on the mediator variable (EA), several studies have 
documented the concurrent relation between AS and EA at a single time point (e.g., 
Kämpfe et al., 2012; Kashdan, Barrios, Forsyth, & Steger, 2006; Zvolensky et al., 2015). 
Second, reflecting evidence for the effect of the mediator (EA) on the dependent variable 
(depression), EA has been shown to be related to concurrent depression both cross-
sectionally (e.g., Leahy, 2002; Tull & Gratz, 2008) and longitudinally (Bohlmeijer, 
Fledderus, Rokx, & Pieterse, 2011; Spinhoven, Drost, de Rooij, van Hemert, & Penninx, 
2014). For example, decreases in experiential avoidance have been shown to mediate the 
effect of an Acceptance and Commitment Therapy (ACT) on subsequent depressive 
symptoms in a community sample of people with depressive symptoms (Bohlmeijer et 
al., 2011). Similarly, EA has been shown to prospectively predict future depression 
among individuals with current emotional disorders or with prior histories of emotional 
disorders (Spinhoven et al., 2014), although this finding was not replicated in a more 
recent prospective longitudinal study (Schut & Boelen, 2017). Third, Tull and Gratz 
(2008) showed cross-sectionally that EA and difficulties engaging in goal-directed 
behavior mediated the relationship between aspects of AS and depressive symptoms. 
Zvolensky and colleagues (2015) replicated this finding and extended it by demonstrating 
a reciprocal relation between EA and AS with respect to depressive symptoms (i.e., AS 
mediated the relation between EA and depressive symptoms, and depressive symptoms 
mediated the relation between EA and AS). Unfortunately, neither study (i.e., Tull & 
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Gratz, 2008; Zvolensky et al., 2015) could provide evidence for causality as all measures 
were assessed at just one time point.   
Aiming to build upon the aforementioned research, this study sought to examine 
the AS-EA-depression pathway longitudinally and prospectively, using a cross-lag 
mediation model. Such models can provide quasi-causal estimates of the mediating 
pathways (Hamaker, Kuiper, & Grasman, 2015). Utilizing data from a study that 
examined the effects of exercise on AS (Smits, Berry, Rosenfield, et al., 2008), we 
modeled the repeated measures of depressive symptoms, EA and AS to test the 
hypothesis that the relation between reductions in AS and depression symptoms over time 
would be mediated by reductions in EA.    
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Chapter 2: Method2 
The present study represents a secondary analysis of published data from a study 
that evaluated the efficacy of exercise for reducing AS in adults with clinically elevated 
AS (Smits, Berry, Rosenfield, et al., 2008). 
PARTICIPANTS  
Participants were (N=60; 45 Female; MAge = 20.68, SD=5.80) individuals with 
elevated AS (ASI score > 25; Peterson & Reiss, 1993). Participants were introductory 
psychology students recruited from a classroom screening survey administered in 
introductory psychology courses (n=50) at a university in the Southwest United States of 
America (USA). The ASI was administered to students in class and potentially eligible 
individuals were invited to participate in an additional phone screen with additional 
screening measures including the Physical Activity Readiness Questionnaire (PAR-Q; 
Thomas, Reading, & Shephard, 1992) and assessment of exclusion criteria. Community 
volunteers (n=10) were recruited from advertisements near a large university in the 
Northeast USA. Participants who responded to these ads were also invited to participate 
in a phone screen, which included the ASI and assessment of readiness for physical 
activity and of inclusion/exclusion criteria. Eligible participants based on the phone 
screens were then invited into the lab to participate.  
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PROCEDURES  
Procedures for this study have been detailed elsewhere (Medina et al., 2014; 
Smits, Berry, Rosenfield, et al., 2008). Briefly, participants were randomized to one of 
the three conditions: prescriptive exercise alone, exercise plus cognitive restructuring, or 
a wait-list control. The active interventions consisted of multiple brief sessions over a 2-
week period. The wait-list control condition consisted of completing assessments at the 
same time intervals as the other conditions. All measures were administered pre-
treatment, mid-treatment (after week 1), post-treatment (after week 2), and at three-week 
follow up (after week 5).  
MEASURES 
 
Anxiety sensitivity. The 16-item Anxiety Sensitivity Index (ASI; Peterson & 
Reiss, 1992) is a self-report questionnaire assessing AS. Using a Likert-type scale, 
(0=very little to 4=very much), participants are asked to rate the degree to which they 
find bodily sensations associated with anxious arousal distressing. The ASI has strong 
psychometric properties, with high internal consistency (alpha = 0.80-0.90) (Peterson & 
Reiss, 1993; Taylor, Koch, & McNally, 1992; Telch, Shermis, & Lucas, 1989), test-retest 
reliability (Maller & Reiss, 1992; Peterson & Reiss, 1993), and construct validity 
(McNally & Lorenz, 1987; Taylor, Koch, & Crockett, 1991). In the current sample, 
internal consistency was mostly good across time points (αPre = 0.61; αMid = 0.87 αPost = 
0.89; αFU = 0.92). 
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Experiential avoidance. The 9-item Acceptance and Action Questionnaire-short 
form (AAQ; Hayes, Strosahl, Wilson, & Bissett et al., 2004) was initially designed to 
measure changes in EA and psychological flexibility during Acceptance and 
Commitment Therapy (ACT). The self-report questionnaire assesses (1) unwillingness to 
experience distress and (2) the extent to which unwillingness to experience distress 
interferes with one’s pursuit of values and goals. Higher scores on the measure reflect 
greater EA tendencies (i.e., lower experiential acceptance and flexibility). Although there 
is now a revised AAQ (AAQ-II; Bond et al., 2011), the 9-item version of the AAQ has 
previously been used to examine experiential avoidance (not only psychological 
flexibility) and has demonstrated satisfactory internal consistency and reliability (Boelen 
& Reijntjes, 2008). In the current sample, internal consistency was variable across time 
points (αPre = 0.56; αMid = 0.57 αPost = 0.70; αFU = 0.67). 
Depressive symptoms. The Beck Depression Inventory-II (BDI-II; (Beck, Steer, 
& Carbin, 1988; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) is a 21-item self-
report measure designed to measure the severity of depressive symptoms over the 
previous week. Higher scores indicate greater symptom severity. The scale has been 
validated for use in college students (Whisman, Perez, & Ramel, 2000) and in a variety of 
clinical and nonclinical samples (Beck et al., 1988). In the current sample, internal 
consistency was good across timepoints (αPre = 0.84; αMid = 0.89 αPost = 0.89; αFU = 0.92). 
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ANALYTIC APPROACH 
We employed a multilevel modeling (MLM) approach using SPSS® Version 23 
to test the hypothesis that EA would mediate the longitudinal relation between AS and 
depression symptom severity. MLM has several advantages over other methods of 
analyzing data involving repeated assessments. As an intent-to-treat (ITT) approach, 
MLM includes all subjects regardless of missing data on the repeated measures; this 
enhances statistical power and overall generalizability. MLM also allows for modeling 
the covariance matrix for the errors at repeated assessments, optimizing model accuracy.  
We proposed an MLM path model (Figure 1) to test the hypothesis that weekly 
levels of self-reported EA (indexed via AAQ) would mediate the longitudinal 
relationship between AS (indexed via ASI) and depression symptoms (indexed via BDI-
II) at the subsequent assessment. We examined the effect of both the between-subjects 
and within-subjects component of each time-varying predictor (TVP) on outcome. This 
required us to disaggregate the original TVP variables for ASI and AAQ into a mean and 
deviation variable and enter separate variables for each in predicting outcome (Hedeker 
& Gibbons, 2006; Hoffman, 2015; Wang & Maxwell, 2015). The “mean” statistic for 
each TVP is a level 2 predictor (i.e., between-subjects), reflecting the individual’s mean 
on that predictor over all four assessments. The deviation variable is a level 1 variable 
(i.e., within-subjects), reflecting the individual’s deviation from their mean at each 
assessment. The primary reasons that we chose cross lag panel autoregressive models 
using disaggregated time varying predictors in MLM are that these models (1) calculate 
within-person relations between the variables across time and that (2) MLM models have 
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been shown to make accurate, unbiased estimates of regression coefficient in small 
samples like ours (Maas & Hox, 2005). 
We predicted that changes in our mediator, AAQ, would predict later changes in 
the outcome, BDI, thus enhancing the causal interpretation of our mediation model 
(Kraemer, Stice, Kazdin, Offord, & Kupfer, 2001). However, given the lack of current 
evidence regarding the expected time frame for the action of the effects to occur between 
ASI, AAQ, and BDI, we explored both prospective and concurrent mediation. In our 
prospective analysis, we expected that disaggregated ASI at the previous assessment 
would predict disaggregated AAQ during the current assessment (i.e., ASI at time “t-1” 
would predict AAQ at time “t”), and that disaggregated AAQ at week “t” would impact 
outcome scores on the BDI at the next assessment (e.g., BDI at week “t+1”), controlling 
for outcome scores from the current week (e.g., BDI at week “t”). This longitudinal 
cross-lagged approach employing the disaggregated TVPs is similar the approach 
recommended by (Hamaker, Kuiper, & Grasman, 2015) for assessing quasi-causal 
relations in non-experimental data.  
In our concurrent model (Figure 2), we conducted these analyses without the lag. 
Across all of our analyses, we controlled for the potential effects of time and study 
condition by including Time (coded 1-4), Condition (coded 0=exercise condition, 
1=control condition), and Time x Condition as covariates.  
Mediation. We evaluated the significance of AAQ as a disaggregated mediator of 
the prospective time-varying relation between ASI and BDI using the distribution of 
products test (Tofighi & MacKinnon, 2011). Mediation is significant if the 95% 
 10 
confidence interval for the a*b product does not include 0 (“path a” is the effect of the 
predictor on the proposed mediator, and “path b” is the effect of the mediator on the 
proposed outcome, controlling for the effect of other independent variables in the model). 
In our cross-lagged MLM model we calculated significance of the indirect a1*b1 
pathway (ASI Deviationt-1 to AAQ Deviation to BDIt+1), in addition to the indirect a2*b2 
pathway (ASI mean to AAQ mean to BDIt+1), as depicted in the model in Figure 1. In 
testing concurrent mediation, we calculated significance of the indirect a1*b1 and a2*b2 
pathways depicted in the path model in Figure 2. As a measure of the effect size of each 
mediated pathway, we calculated the proportion mediated (PM = (a*b)/c; Shrout & 
Bolger, 2002). PM represents the proportion of the total effect of the IV on the DV that is 
mediated by the mediator. 
We used the MLM power analysis program PinT 2.12 (Power in Two-Level 
Models, Snijders & Bosker, 1993) to calculate the power to detect significance for the 
paths in our mediation models. We used the data in the current sample to calculate the 
level-1 and level-2 variances and covariances needed by PinT to make these calculations. 
PinT indicated that we had power=.92 to detect a medium effect size (d=.50) for the “a” 
and “b” paths in the concurrent mediation analysis (with 4 data points per participant), 
and power=.86 to detect a medium effect size for the “a” and “b” paths in the cross-lag 
analysis (with 3 lagged data point per participant).  
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Chapter 3: Results3 
SAMPLE CHARACTERISTICS 
 
 Descriptive statistics can be found in Tables 1 and 2. The distributions of the 
variables of interest (ASI, AAQ, BDI) showed acceptable levels of skewness (AAQ = -
0.36; ASI = -0.27; BDI = 0.71) and only 1 outlier > 3SD from the mean (no value > 4 
SDs from the mean). There was no missing data on the only between subjects variable in 
the analysis (treatment condition). Missing data for each variable of interest was: 35 out 
of 240 possible assessments of ASI (14.58%), 35 out of 240 on AAQ (14.58%), and 35 
out of 240 on BDI (14.58%). The pattern of missing data was such that if a participant 
was missing data on a given variable of interest for a given time point (e.g., missing ASI 
at post-treatment time point 3), he/she was missing data on the remaining variables for 
that assessment (e.g., missing BDI and AAQ at post-treatment time point 3). Fifteen 
participants missed at least one assessment survey containing the AAQ, ASI, and BDI4. 
Average ASI at baseline for our sample (inclusion criterion: ASI>25) was 33.48 
(SD=6.45). Baseline mean AAQ for the sample was 40.72 (SD=6.28), consistent with 
levels of EA found in other studies conducted in patients with anxiety and mood concerns 
(Berman, Wheaton, McGrath, & Abramowitz, 2010). BDI-II at baseline was 13.30 
(SD=7.08), which is indicative of minimal-to-mild depressive symptoms. Results from 
                                               
3 The Version of Record of this manuscript has been published and is available in Cognitive Behaviour 
Therapy (2018) http://www.tandfonline.com/10.1080/16506073.2018.1546768. All authors contributed 
equally to the publication of this manuscript. 
4 Although MLM is robust to missing data, to strengthen the assumption that missing data did not influence 
our results, we retested our hypothesis filtering out the n=15 participants with missing data. Results from 
MLM of n=45 did not differ from those yielded by the entire sample of N=60 participants.  
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the main outcome paper indicated a steeper decline in both ASI (t (57) = -8.29, p < .001) 
and BDI-II (t (57) = -3.94, p < .001) in the exercise relative to control condition (Smits, 
Berry, Rosenfield, et al., 2008). Current analyses revealed that there also was a 
significantly greater decline in AAQ scores in the exercise relative to control condition (b 
= -2.22, t (58) = -4.30, p < .001).  
HYPOTHESIS TESTING 
Prospective Model Path Analysis. Results for path “a1” showed that, controlling 
for Time, Condition, Time x Condition, and AAQ Deviationt-1, ASI Deviationt-1 did not 
predict AAQ Deviationt (b =.110, t(130) = 1.665, p = .098). As expected, AAQ 
Deviationt-1 predicted AAQ Deviationt, b = -.277, t(131) = -3.449, p = .001, indicating that 
AAQ deviations from their mean in a given week negatively predicted deviations from 
their mean in the subsequent week (perhaps reflecting regression to the mean). In 
evaluating path “a2”, ASI Mean was related to AAQ Mean, b = 0.361, t(59) = 4.260, p < 
.001, indicating participants with higher average levels of ASI tended to report higher 
average levels of EA on the AAQ. 
Controlling for Time, Condition, Time x Condition, disaggregated ASI (ASI 
Deviationt and ASI Mean), and current levels of BDIt, results for the “b1” and “b2” paths 
showed that neither AAQ Deviationt (b = -0.094, t(124) = -.834, p = .406), nor AAQ 
Mean (b = .111, t(115) = 1.418, p = .159), predicted BDIt+1. Current BDIt predicted 
subsequent BDIt+1, b = 0.699, t(115) = 11.11, p < .001. Neither ASI Deviationt (p = .308), 
nor ASI Mean (p = .601) (i.e., c’ paths) were significant.  
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Test of Prospective Mediation. The distribution of products test showed that the 
mediated pathway from deviations in ASIt-1 to deviations in AAQt to subsequent BDIt+1 
was not significant, a1*b1 = -0.010 (SE = 0.027), 95% CI: [-0.077, 0.037], p>.05. 
Similarly, the mediated pathway from ASI mean to AAQ mean to BDIt+1 was not 
significant, a2*b2 = 0.040 (SE = 0.031), 95% CI: [-0.016, 0.107], p>.05. Thus, AAQ did 
not mediate the relation between ASI and BDI in the prospective model.  
Concurrent Model Path Analysis. Controlling for Time, Condition, and Time x 
Condition, results for path a1 showed that ASI Deviationt were related to AAQ 
Deviationt, b = 0.22, t(169) = 4.379, p < .001, indicating when participants reported 
higher than their average level of ASI, they also reported higher than their average level 
of AAQ. Results for path a2 in the concurrent model are the same as those reported above 
for the prospective model.  
Controlling for Time, Condition, Time x Condition, and disaggregated ASI (ASI 
Deviationt and ASI Mean), results showed that AAQ Deviationt  (b = 0.187, t(196) = 
1.431, p = .154) did not predict BDIt (path b1). However, AAQ Mean, b = 0.571, t(193) = 
7.160, p < .001, did predict BDIt (path b2). Neither the ASI Deviationt effect on BDIt (c1’ 
path), (p = .271), nor the ASI Mean effect on BDIt (c2’ path) (p = .467), was significant. 
Test of Concurrent Mediation. The distribution of products test showed that the 
mediated pathway from ASIt deviations to AAQt deviations to concurrent BDIt was not 
significant, a1*b1 = 0.042 (SE = .031), 95% CI: [-.014, 0.108], p>.05. However, the 
mediated pathway from mean ASI to mean levels of AAQ to BDIt was significant, a2*b2 
= 0.205 (SE = .059), 95% CI: [0.098, 0.330], p<.05, PM=63.41%. These latter results 
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indicate that between-subjects variability in average AAQ levels mediated the concurrent 
relation between mean level of ASI and BDI.  
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Chapter 4: Discussion5 
 
The current study aimed to test whether EA mediates the relation between AS and 
depressive symptom severity. While previous research has supported this pathway cross-
sectionally, the current study was the first to examine this longitudinally. Consistent with 
prior research (Tull & Gratz, 2008; Zvolensky et al., 2015), we found that EA mediated 
the concurrent, between-subjects association between mean levels of AS and depression 
symptom severity. However, analyses testing EA as a quasi-causal mediator in the AS-
depression symptom severity relation using a prospective model – that is, the cross-
lagged AS to EA to depression symptom severity pathway – failed to support our 
hypothesis. The discrepancy between the concurrent, between-subjects finding and the 
prospective, cross-lag findings underscores the importance of estimating causal pathways 
in mediation analyses, as solely relying on concurrent relations or between-subjects 
analyses may yield false positives (Maxwell & Cole, 2007). 
There are a number of potential explanations for this discrepancy. First, it is 
possible that the time between assessments does not accurately reflect the time-course of 
the effect. Specifically, it is possible that the effects of EA on depressive symptoms are 
either immediate or shorter than the time between assessments in this study. If the effects 
are immediate, then it is possible that the effects could be washed out before the 
following assessment point, which could explain why the lagged model was not 
                                               
5 The Version of Record of this manuscript has been published and is available in Cognitive Behaviour 
Therapy (2018) http://www.tandfonline.com/10.1080/16506073.2018.1546768. All authors contributed 
equally to the publication of this manuscript. 
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significant. Future research should determine the time course of the effect of each 
variable in order to optimize the time between measurements. Second, it is also possible 
that the lack of mediation findings may be due to variable or suboptimal reliability for the 
ASI and AAQ. It is possible that updated versions of these measures (e.g., AAQ-II; Bond 
et al., 2011or ASI-3; Taylor et al., 2007) would have yielded different results. Finally, it 
is possible that the significant between-subjects, concurrent mediation analysis does not 
reflect a true mediation effect. Rather, it may represent relations between variables that 
may be caused by either third variable confounds (e.g., people with more severe problems 
having higher scores on all the measured variables) or reverse relations. Since the 
previous investigations of the relations among AS, EA, and depression were primarily 
between-subjects studies, our findings suggest that it is possible that these previous 
findings may have been a result of third variable confounds also. 
Unfortunately, in this initial study testing the relation between AS and depressive 
symptom severity, we opted to focus only on EA as a mediator, consistent with the model 
outlined by Otto and colleagues (2016). Due to power constraints and the desire to 
minimize the complexity of these models, we focused our analysis on testing the specific 
AS to EA to depression model proposed by Otto et al. (2016) and therefore did not to 
control for potential third variable confounds, such as anxiety or self-efficacy. 
We should point out that we did find a longitudinal, within-subjects relation 
between ASI and EA in the concurrent mediation analysis. Had we not failed to obtain a 
significant relation between ASI and EA in the cross-lag mediation analysis, we perhaps 
would take this as some evidence supporting at least the first step in the ASI to EA to 
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depression mediation pathway. However, since this relation was not evident in the cross-
lag analysis, it suggests that the obtained relation may be due to some other within-person 
change variable (e.g., self-efficacy) or to reverse causation. But there also remains the 
possibility that the ASI to EA link is causal, just that we weren’t able to detect it because 
our lag was not correct, our measures were not optimal, or our power was insufficient. 
Encouraging replication and extension, we suggest that researchers consider a 
number of measurement issues to improve upon this study and its findings. First, we 
recommend that tests of causality be complemented by tests of specificity, such that 
several putative mediators are entered into models simultaneously (Smits, Julian, 
Rosenfield, & Powers, 2012). Second, replication with a larger sample is warranted. It is 
possible that we did not have sufficient power to detect a small effect in the lagged model 
(the effects in the lagged model would likely be smaller than the effects in the concurrent 
model since relations in the lagged model may be attenuated by the passage of time and 
by controlling for reciprocal causation). Finally, it is also possible that the depression 
symptom severity of the sample was too mild to detect an effect. Future research in a 
sample of participants with major depression is warranted.  
Despite these limitations, this is the first study to examine the AS-EA-Depression 
mediated pathway longitudinally. While some of our between-subjects findings are 
consistent with the hypothesis that part of the relationship between anxiety sensitivity and 
depression may be explained by experiential avoidance, the causal nature of this 
relationship and the specificity of this relationship remain unclear. Clinically, these 
results provide further support for the malleability of dispositional risk factors (i.e., AS 
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and EA) for the development and maintenance of psychopathology. Although these 
relationships have not yet been tested in clinical samples, our results support the viability 
of interventions targeting AS for prevention of a broader range of psychopathology, 
including depression.  
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Tables and Figures 
Table 1. Descriptive Statistics for Outcome Measures 
 
 Waitlist Exercise Exercise + CR 
 n M SD n M SD n M SD 
ASI          
  Pretreatment 20 34.55  6.62  19 34.32  7.02  21 31.71  5.61  
  Mid-treatment 19 32.58  7.46  17 24.29  8.15  14 21.36  11.32  
  Posttreatment 19 30.21  6.24  16 14.50  6.52  14 14.35  10.43  
  Follow-up 16 29.94  7.99  16 12.25  6.59  14 10.57  7.44  
BDI          
  Pretreatment 20 13.43  6.21  19 13.16  7.98  21 13.31  7.33  
  Mid-treatment 19 13.76  7.38  17 9.35  6.12  14 8.14  8.75  
  Posttreatment 19 12.58  7.13  16 5.75  4.19  14 7.07  7.31  
  Follow-up 16 13.44  8.89  16 5.13  4.56  14 5.86  7.53  
AAQ-II          
  Pretreatment 20 40.15 6.89 19 39.68 6.57 21 42.29 5.33  
  Mid-treatment 19 39.53 7.21 17 37.47 5.82 14 38.86 5.488  
  Posttreatment 19 39.47 8.03 16 34.06 6.71 14 36.07 7.41 
  Follow-up 16 38.69 7.31 16 33.75 6.92 14 33.68 7.05  
 
 
 
  
 20 
Table 2. Descriptive Statistics and Correlations for Outcome Measures  
 
 
 
 
 
 
 
 
 
Note: *p <.05, **p <.01, ***p<0.001. AAQ = Acceptance and Action Questionnaire; ASI 
= Anxiety Sensitivity Index; BDI-II = Beck Depression Inventory-II. Mean, standard 
deviation, and correlation coefficients represent average across all timepoints.  
  
  1 2 3 4 M SD 
AAQ - Total ---    38.08 7.11 
      
  
ASI – Total .48*** ---   25.22 11.43  
    
  
BDI - Total .56*** .46*** ---  10.45 7.64 
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Figure 1. Results of Cross-Lagged Mediation Model  
 
 
 
Note. (Coefficient b, std. error); p < .001***, p < .01**, p < .05*. We controlled for the 
effects of study condition and time by including covariates, Condition and Time, at each 
step of the analysis. Mediation pathway indirect effect estimate, a1*b1 = -0.010 (SE = 
0.027), 95% CI: [-0.077, 0.037]; indirect effect estimate, a2*b2 = 0.040 (SE = 0.031), 95% 
CI: [-0.016, 0.107]. 
  
ASI Deviationt-1
AAQ MeanASI Mean
AAQ Deviationt
BDIt+1
a1 (b=0.11, SE=0.07)
b1 (b=-0.09, SE=0.11)
b2 (b=
0.11, 
SE=0.
08)
a2 (b=0.36, SE=0.09)***
BDIt
c1’ (b=-0.09, SE=0.09)
c2’ (b= 0.03, SE=0.06)
(b=0.70, SE=0.06)***AAQ Deviationt-1  (b=-0
.28, S
E= 0.0
8)**
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Figure 2. Results of Concurrent Mediation Model  
  
 
 
Note. (Coefficient b, std. error); p < .001***, p < .01**, p < .05*. We controlled for the 
effects of study condition and time by including covariates, Condition and Time, at each 
step of the analysis. Mediation pathway indirect effect estimate, a1*b1 = 0.042 (SE = 
.031), 95% CI: [-.014, 0.108]; indirect effect estimate, a2*b2 = 0.205 (SE = .059), 95% 
CI: [0.098, 0.330], PM=63.41%. 
 
 
 
 
 
 
 
  
ASI Deviationt
AAQ MeanASI Mean
AAQ Deviationt
BDIt
a1 (b=0.22, SE=0.05)*** b1 (b=0.19, SE=0.13)
b2 (b=
0.57, 
SE=0.
08)**
*
a2 (b=0.36, SE=0.09)***
c1’ (b=0.11, SE=0.10)
c2’ (b=0.05, SE=0.07)
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